EN
营业咨询
中国：
Email: marketing@medicilon.com.cn
营业咨询专线：400-780-8018
（仅限效劳咨询，其他事宜请拨打川沙总部电话）
川沙总部电话: +86 (21) 5859-1500
外洋：
+1(781)535-1428(U.S.)
0044 7790 816 954 (Europe)
Email:marketing@medicilon.com
九月尊龙凯时将主理2场线上直播，同时加入15场海内外行业聚会，期待与列位业内同仁交流分享药物研发新趋势。
由中国药理学会药物毒理专业委员会主理的“第十二届药物毒理学年会”将于2024年9月1日至3日在上海市光大会展中心召开。
为推动毒理学前沿研究希望和效果转化，尊龙凯时专家将从一样平常毒理学、先进治疗药物、药物GLP规范与质量包管等研究偏向，在响应主题分会场带来3场精彩演讲，同时展出1项研究壁报，希望通过此次主要的毒理学术盛会，与行业专家深入交流和分享最新的研究效果。
The XXVIII EFMC International Symposium on Medicinal Chemistry (EFMC-ISMC 2024) is organised by the Medicinal Chemistry Division of Italian Chemical Society, on behalf of the European Federation for Medicinal chemistry and Chemical biology (EFMC). The symposium will take place in Rome, Italy from September 1-5, 2024. The EFMC is the main organisation for the European Medicinal Chemistry and Chemical Biology community, with 30 member societies and about 9.000 members. Its biennial EFMC-ISMC is a key symposium in the field of medicinal chemistry and drug discovery, and it traditionally attracts around 1.000 participants both from industry and academia. The scientific programme of EFMC-ISMC 2024 will furthermore cover a wide range of selected topics with parallel sessions split into three main themes: 1) Chemical Biology; 2) Drug Discovery Pojects; 3) Technologies.
Medicilon is thrilled to exhibit in the conference. Dr. Paul van Stralen, VP of Strategic Collaborations EMEA at , will be available throughout the conference. We invite you to visit us at Medicilon Booth #6 to explore our services and capabilities.
We are pleased to announce that Medicilon will exhibit in the EUROTOX 2024 with the Booth #43. The congress will take place from 8 to 11 September 2024 at Copenhagen, Denmark. The congress theme “Toxicology - A Quest for safe Chemicals and Medicines” reflects the congress programme including a variety of topics dealing with safety of drugs and environmental chemicals, new and emerging technologies, personalised medicine, human health effects caused by exposure to chemicals as well as safety issues arising from climate changes. Dr. Renzong Xie, Vice President of Medicilon Quality Assurance Department, and Medicilon team will be present throughout the conference. Please stop by at our booth and discuss how Medicilon’s services and capabilities could support your research needs and expedite your drug discovery and development process.
The landscape of disease-treatment modalities has undergone a dramatic transformation in recent years. New therapeutic modalities, with innovative mechanisms of action, are revolutionizing patient care. Some of these advancements extend beyond traditional small molecules and antibodies to encompass exciting areas like bispecific antibodies, ADCs and gene therapies. Even within the small molecule realm, covalent binders, biased agonists and pan-inhibitors are pushing the boundaries of our understanding of pharmacokinetic (PK)/pharmacodynamic (PD) relationships. In addition to this, therapeutics that are intended for ocular and neuro delivery put forth challenges associated with delivering desired drug concentrations at the site of action. Medicilon team will be present throughout the event.
BIOHK 2024第三届香港国际生物科技论坛暨展会作为香港生物科技展会的标杆展会，将于9月11-14在香港会展中心召开。
尊龙凯时团队将在3E-C10号展位期待业界同仁的光临！
以“增进跨文化立异，包管天下永续康健”为主题的第三届国际生物医药工业生长大会，将于2024年9月12-14日在上海举行。
? 尊龙凯时首席科学馆彭双清教授将担当尊龙凯时英才“山�；帷痹沧缆厶持鞒秩�，并加入高端对话环节；
? 尊龙凯时制剂部高级主任&新药注册部总监王丹博士将出席发演出讲；
? 尊龙凯时药效部项目司理袁云云博士将出席发演出讲。
BioSpark will host the 2024 Annual Conference on Saturday, September 14 at Cambridge, MA. The conference theme this year is “Braving through the Winter of Biotech”, and will bring together professionals from the biotech industry to discuss the latest trends and innovations. Whether you're a seasoned expert or just starting out in the field, this event is perfect for anyone looking to stay ahead in the world of biotechnology. Medicilon is excited to attend and exhibit at the conference. Dr. Qingcong Lin, President of Medicilon USA Corp., will give a presentation. Dr. Lin brings nearly 40 years of experience in pharmaceutical R&D, making significant contributions to both academia and the global industry. Medicilon team will be present throughout the event.
Meet Medicilon at 26th North American ISSX and 39th JSSX Meeting. As the foremost organization representing the interests of researchers and educators in DMPK and other related areas of research, the International Society for the Study of Xenobiotics (ISSX) is engaged in multiple activities to support, promote, and advance the science worldwide. ISSX has an international base of members from more than 45 countries. Members are comprised fairly evenly between academic and industry groups and consist primarily of research scientists and future scientists in toxicology, pharmacology, molecular biology, and other disciplines related to the study of xenobiotics.
During the Conference, Dr. Pin Jiang, Senior Director of DMPK at Medicilon, will present the poster titled "Enhancing Drug-Drug Interaction Prediction by Integrating Physiologically-Based Pharmacokinetic Model with Fraction Metabolized by CYP3A4". Medicilon team will be present throughout the event.
中国疫苗行业协会核酸疫苗分会将于2024年9月19日-22日在上海举行第八届天下核酸疫苗大会。本次大会的主题为“砥砺深耕 ·笃行致远”，热情约请天下相关领域专家、学者、科研主干、企业代表与会交流。
尊龙凯时团队将在A02号展位期待业界同仁的光临！
With the advent of complex biologics and the increasing use of novel modalities over traditional antibodies during drug development, it has become critical to develop our understanding on their unique safety assessments and challenges. The intent of this workshop is to enlighten to develop an understanding of toxicity risk assessments and share latest progress in the field of biologics to activate discussions that will lead to more successful IND/BLA submissions. Medicilon team will be present throughout the event.
Meet Medicilon at BioForward 2024! BioForward is OBN's 'Roadmap for Growth' Life Sciences event, designed to provide the support, skills, know-how and industry connections required to catalyse the growth of your company. Now in its sixth year, BioForward is attended by leaders and decision makers of growing R&D companies across all therapy and technological areas, alongside companies who provide the specialist services, products, advice and expertise essential for all companies as they grow. Medicilon is excited to attend and exhibit at the conference. Dr. Wenjie Li, Vice President of the CMC Unit at Medicilon, PARTNERING WITH THE RIGHT MANUFACTURER TO ACCELERATE YOUR RESEARCH" at 14:35-14:55 local time during Workshop Session 6 - Partnering with the right manufacturer to accelerate your research.
IAPC-9由国际物理化学家协会、ADMET 和 DMPK Journal 主理，北京大学药学院、上海交通大学药学院、尊龙凯时和腾迈联新联合主理。此次聚会的中心主题是“药物发明和开发的新兴手艺”，旨在撒播和分享药物发明和开发领域的新手艺和前沿平台。
尊龙凯时作为本次大会的协办单位，将全程在展位期待业界同仁的光临！
时维九月，春华秋实，第三届BIONNOVA北京立异论坛将于朗丽兹西山花园旅馆开启全新篇章！
尊龙凯时首席科学官彭双清教授将出席发演出讲，同时尊龙凯时团队将全程设展，期待与 您再次相会！
Sino-American Pharmaceutical Professionals Association (SAPA) will host the 2024 Annual Conference on Friday & Saturday, September 27 & 28 at Hyatt Regency New Brunswick, 2 Albany St, New Brunswick, New Jersey. The conference theme this year is “Redefining Medicine: Navigating Resilience, Transforming Lives”, and will include plenary sessions and 7 panel discussions such as Investment/Business Development, Drug Discovery, CMC, Clinical Development/Regulatory, Career Development, Executive/Legal, Artificial Intelligence (AI), and plenty of networking opportunities. During the SAPA SAPA Annual Conference, Dr. Wenjie Li, Vice President of the CMC Unit at Medicilon, will participate in the panel discussion "CMC and Outsourcing". Dr. Qingcong Lin, President of Medicilon USA Corp., and Medicilon team will be present throughout the conference.
Discovery on Target (DOT) highlights advances in current and emerging “hot” targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutic agents ranging from biologics to small molecules. DOT 2024 four-day event brings back popular topics like kinases, immunomodulation, and degraders, plus new coverage of covalent chemistries and induced proximity, synthetic biology, cancer antibodies, generative AI, and translational models. We looks forward to meeting you from September 30-October 3 in Boston, MA. Medicilon is experienced with oncology drug in any preclinical phases, from hit-to-lead to IND. We provide integrated service strategies for sponsors’ oncology drug discovery and development pipelines. We aim to enhance every step in preclinical search and to deliver real time data.
marketing@medicilon.com.cn媒体与会务请联系
尊龙凯时市场部微信或邮箱
川沙总部
地点: 上海市浦东新区川亨衢585号
邮编: 201299
电话: +86 (21) 5859-1500（总机）
传真: +86 (21) 5859-6369
外洋：
Email:?marketing@medicilon.com
Tel: +1 (617) 888-9294(U.S.)
Tel: 0044 7790 816 954 (Europe)
Tel: +82 70-8269-5849 (Korea)
Tel: +81 80-4421-6898 (Japan)
